Saw Palmetto

Research Reliability -

A palm berry extract that supports prostate health, urinary function, and hormonal balance in men.

Appetite

Mood

Sleep

Saw Palmetto
Saw Palmetto

Description

Saw palmetto (Serenoa repens) extract is one of the most studied botanical interventions for benign prostatic hyperplasia (BPH), a common condition in men over 50 characterized by urinary symptoms from prostate enlargement. Its primary mechanism involves inhibiting 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT), which drives prostate cell proliferation. It may also reduce DHT-related hair follicle miniaturization, making it relevant for men concerned about androgenic hair loss. Clinical evidence supports improvements in urinary flow, frequency, and nighttime urination with consistent use.

Effects
First weeks

no felt change

Weeks 4–12

urinary flow and frequency may improve

urinary flow and frequency may improve

Ongoing

prostate and DHT-related support

prostate and DHT-related support

How It Feels

This is a slow, quiet supplement; men taking it for urinary symptoms may notice easier, less frequent trips to the bathroom after a couple of months. There is no acute effect. Consistency over weeks is what matters.

Evidence

Evidence Strength

Moderate (some human RCTs)

Caveats

This Cochrane review found saw palmetto performed no better than placebo for BPH symptoms, even at higher doses. This directly contradicts its popular reputation as a prostate-support supplement.

Usage
Commonly Referenced Starting Amount

160 mg extract/day

Commonly Referenced Amount

320 mg/day is the standard dose studied for BPH symptoms

Referenced Upper Limit

No upper limit has been established. Worth knowing plainly: a 2023 Cochrane review of 27 trials and over 4,600 men found saw palmetto alone provides little or no benefit over placebo for BPH symptoms, and a large trial testing 2–3 times the standard dose found no advantage over placebo either. This is a case where the marketing has outrun the evidence

Onset

4–12 weeks (prostate/DHT)

Biomarkers to Track
Subjective

(Daily)

  1. Urinary urgency frequency

  2. Nighttime urination frequency

  3. Urinary flow strength (1–10)

Objective

(Quarterly)

  1. PSA (prostate-specific antigen)

  2. DHT serum level

  3. Urinary flow rate (uroflowmetry)

Risks
Risks
Risks

Very safe. It can lower PSA readings and has mild blood-thinning.

Who Should Skip
Who Should Skip
Who Should Skip

Men should tell their doctor before a PSA test, and blood-thinner users should note the effect.

Common Mistakes
Common Mistakes
Common Mistakes

Not mentioning it before prostate screening, and expecting quick results.

Disclaimer

This information is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any new supplement, especially if you are pregnant, nursing, taking medication, or managing a health condition.

Citations
Citations
Citations

Tacklind J et al. (2012). Cochrane Database of Systematic Reviews. Meta-analysis (saw palmetto for benign prostatic hyperplasia). PMID: 23235581.

The content on this site is provided for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. Aambrosia sells subscription access to editorial and research content only, no supplement, compound, or other physical product discussed on this site is sold, shipped, or dispensed by Aambrosia. Always consult a qualified healthcare provider before making changes to your diet, supplement routine, or health practices. Aambrosia does not guarantee specific results, and individual outcomes may vary

Business Address: Dunn Dr, Culver City, CA, 90232
Support: support@aambrosia.com